Cytotoxic Activity, Cell Cycle Inhibition, and Apoptosis-Inducing Potential of <i>Athyrium hohenackerianum</i> (Lady Fern) with Its Phytochemical Profiling

Elasbali, Abdelbaset Mohamed; Al-Soud, Waleed Abu; Al-Oanzi, Ziad H.; Qanash, Husam; Alharbi, Bandar; Binsaleh, Naif K.; Alreshidi, Mousa; Patel, Mitesh; Adnan, Mohd

doi:https://doi.org/10.1155/2022/2055773

Evidence-Based Complementary and Alternative Medicine

On this page

Abstract Introduction Materials and Methods Results Discussion Conclusion Data Availability Conflicts of Interest Authors’ Contributions Acknowledgments References Copyright Related Articles

Special Issue

Natural Products Potentiate the Anticancer Effect of Chemotherapeutics

View this Special Issue

Research Article | Open Access

Volume 2022 | Article ID 2055773 | https://doi.org/10.1155/2022/2055773

Cytotoxic Activity, Cell Cycle Inhibition, and Apoptosis-Inducing Potential of Athyrium hohenackerianum (Lady Fern) with Its Phytochemical Profiling

Abdelbaset Mohamed Elasbali,^1,2Waleed Abu Al-Soud,³Ziad H. Al-Oanzi,³Husam Qanash,^4,5Bandar Alharbi,⁴Naif K. Binsaleh,⁴Mousa Alreshidi,^5,6Mitesh Patel,⁷and Mohd Adnan⁶

Academic Editor: Mohammed El-Magd

Received14 Mar 2022

Revised10 Apr 2022

Accepted12 May 2022

Published02 Jun 2022

Abstract

In the present study, we investigated the cytotoxic effects of Athyrium hohenackerianum ethanolic extract (AHEE) on the proliferation of breast, lung, and colon cancer cells. The AHEE was tested for its effect on the progression of the cell cycle, followed by induction of apoptosis determination by flow cytometry. Real-time qRT-PCR was also utilized to observe the initiation of apoptosis. In addition, GC-MS was performed in order to identify the active phytochemicals present in the AHEE. A cytotoxic activity with an IC₅₀ value of 123.90 μg/mL against HCT-116 colon cancer cells was exhibited by AHEE. Following propidium iodide staining, annexin-V/PI, and clonogenic assays, AHEE treatment results in cell arrest in the S phase, causing an increase in the early and late phases of apoptosis and displaying antiproliferative potential, respectively. The morphological alterations were further monitored using acridine orange/ethidium bromide (AO/EB) staining. When compared with the control cells, features of apoptotic cell death, including nuclear fragmentation, in the AHEE-treated cells were noticed. The apoptosis was also confirmed by detecting the increased expression of p53 and caspase-3 along with the downregulation of Bcl-2. GC-MS analysis revealed that trans-linalool oxide, loliolide, phytol, 4,8,12,16-tetramethylheptadecan-4-olide, and gamma-sitosterol were the major phytochemical constituents. Based on these findings, it can be suggested that AHEE causes cellular death via apoptosis, which should be further explored for the identification of active compounds responsible for these observed effects. Therefore, AHEE can be used in the pharmaceutical development of anticancer agents for cancer therapeutics.

1. Introduction

Around the globe, cancer-related deaths are increasing as the incidence of cancer continues to rise [1]. As per the World Health Organization (WHO), colorectal cancer, lung cancer, and breast cancer are the three most frequently diagnosed cancers globally and remain the foremost reason of cancer-related deaths throughout the world [2]. Conventional cancer treatments are still the most common form of treatment, despite being mainly unsuccessful and causing many deaths due to side effects. In contrast, developing new cancer treatments derived from natural sources with fewer side effects has become an exciting field of research [3]. Plants are regarded as a potential repository of novel chemical compounds for cancer research [4]. Many well-known anticancer compounds such as paclitaxel and camptothecin have been reported from plants [5]. India, a biogeographically different region, provides a remarkably rich source of different medicinal plants with anticancer properties [6].

Athyrium Roth, commonly known as the lady fern, is one of the cosmopolitan genera in the Athyriaceae family, containing about 300 species distributed around the world. The plants are terrestrial or epilithic, with erect or ascending rhizomes. In diverse areas of the globe, different species of Athyrium are used as traditional medicine. There is a tradition that A. filix-femina (L.) Roth is utilized with honey for cough treatment in Italy, Province of Salerno, Campania region [7], and its decoction has been used for antiparasitic and antihelminthic purposes [8, 9]. Rhizomes are also used as antiparasitic and antihelminthic agents in Iran as well [10]. A. pectinatum (Wall. ex Mett.) T. Moore was used by the Rajasthan Bhils (Indian tribe) as an antihelminthic [11, 12]. Fresh leaf juice of A. asperum (Blume) Milde was used as an antihelminthic as well as a carminative in the Mymensingh district of Bangladesh [13]. In Madhya Pradesh (India), A. falcatum Bedd. has been used as an antihelminthic [14]. In South India, its roots and fronds were utilized in traditional medicine by the people of the Palani Hills (Western Ghats). As an example, young fronds were consumed as a treatment for cancer and roots were consumed as an antihelminthic [15]. During childbirth, the roots of A. lanceum T. Moore are used to relieve pain, particularly breast pain. Besides enhancing milk flow, it is also effective on sores when applied topically [15]. Furthermore, it is used in Malaysia to treat ascariasis, burns, and intestinal fever [16], as well as burns and scalds. The Athyrium plant is used to treat sores in New Guinea [17]. In traditional Chinese medicine, A. multidentatum has been used as a tranquilizer, antihypertensive, and diuretic [18–20].

A. hohenackerianum T. Moore is native to India and Sri Lanka (Figure 1). In India, it is found in different states such as Goa, Gujarat, Jharkhand, Himachal Pradesh Karnataka, Kerala, Maharashtra, Madhya Pradesh, Odisha, Rajasthan, and Tamil Nadu. In India, the rhizome and fronds of A. hohenackerianum are used as a decoction for rheumatic pain and as an antihelminthic. The rhizome paste is also used against scorpion stings [21]. To our knowledge, there are no reports regarding any biological activity or phytochemistry of A. hohenackerianum. Thus, this study is the initial and first report documenting the anticancer potential and phytoconstituents analysis of A. hohenackerianum grown in India.

(a)

(b)

(c)

(d)

(e)

2. Materials and Methods

2.1. Collection of Plant Material and Extraction

The collection of A. hohenackerianum whole plants was carried out in the South Gujarat region of Gujarat state, India, in September 2020. The voucher specimen (BVBRC042) was deposited at Bapalal Vaidya Botanical Garden, Department of Biosciences, Veer Narmad South Gujarat University, Surat, Gujarat, India. The collected plant material was washed with tap water, and then, deionized water was used to rinse. Thereafter, it was dried under shade at room temperature for 7 days. Upon drying, the samples were ground into powder and were then passed through a sieve that had a mesh size of 20 (sieve size 0.85 mm). 25 g powder of the whole plant of A. hohenackerianum was macerated in 85% ethanol in an electric shaker at the room temperature for 6 h. After filtering through Whatman filter paper No. 1, the extract solution was evaporated in a water bath at 60°C for 2 h. A total of 3.40 g of the extract was recovered, which was brown in color, solid in appearance, and bristle in texture.

2.2. Cytotoxicity by MTT Assay

The AHEE was tested against human lung (A549), breast (MCF-7), and colon (HCT-116) cancer cells. The National Centre for Cell Science (NCCS), Pune, India, provided cell lines for use in this study. Cancer cell lines were cultured in flasks (25 cm²) with 10% fetal bovine serum (FBS) (MP Biomedicals, Germany) in Dulbecco’s Modified Eagle’s Medium (DMEM) (MP Biomedicals, Germany) and 10,000 U/mL penicillin and 5 mg/mL streptomycin antibiotic solution (Hi-Media, India) at 37°C in a humidified atmosphere with 5% CO₂. Upon reaching 80% confluence, the cells were seeded at a density of greater than 1 × 10⁵ cells per well in 96-well plates and incubated in the same conditions as above. Trypan Blue (Hi-Media, India) (0.4%) was used to stain the cells, and a hemocytometer was used to determine the viability. Afterward, cells were treated with AHEE at different concentrations (1.56–200 μg/mL) for 48 h. The plate was removed from the incubator, and the media containing AHEE was aspirated. Then, 200 μL of medium containing 10% MTT reagent (MP Biomedicals, Germany) was added to each well to get a final concentration of 0.5 mg/mL, and the plates were incubated for a further 3 h at 37°C in a humidified atmosphere with 5% CO₂. This was then followed by the removal of the medium and the addition of 100 μL DMSO (Merck, Germany) to dissolve the formazan crystals. Using the ELISA reader (EL10 A, Biobase, China), the absorbance of the amount of formazan crystal was measured at 570 nm and 630 nm. The percentage growth inhibition was calculated after subtracting the background and the blank, and the concentration of the test drug needed to inhibit cell growth by 50% (IC₅₀) was calculated from the dose-response curve for the respective cell line. As a positive control, cisplatin was used [22].

2.3. Cell Cycle Analysis

The flow cytometer was used to evaluate the cell cycle using propidium iodide (PI) staining. In a six-well culture plate, HCT-116 cells were plated at 5 × 10⁴ cells per 2 mL and incubated in a CO₂ incubator for 24 h at 37°C. After incubation, the spent medium was aspirated and washed with 1 mL of 1X PBS. Cells were treated with AHEE (IC₅₀) concentration in 2 mL of the culture medium and further incubated for 24 h. One well was left blank as untreated, which was considered as a negative control. The floating and attached cells were collected and washed with chilled PBS. Following permeabilization, the cells were fixed for 1 h at 4°C in ice cold 70% ethanol. A staining solution (50 μg/mL PI and 20 μg/mL RNase A in PBS) was then added to the cells for 15 min at 37°C. Samples were mixed well and analyzed with the Cytomics FC500 Flow cytometer, Beckman Coulter, USA [23].

2.4. Fluorescent Double Staining with Acridine Orange/Ethidium Bromide (AO/EB)

The cells were plated at a density of 3 × 10⁵ cells/2 mL in 6-well plates and incubated at 37°C for 24 h in a CO₂ incubator. After aspirating the spent medium, 1 mL of PBS was added. The cells were treated with AHEE (IC₅₀) and further incubated for 24 h. For the second time, the medium was removed after incubation and washed in cold PBS. After that, the cells were suspended in 500 μL of AO/EB staining solution (10 μL of acridine orange (2 mg/mL) and 10 μL of ethidium bromide (2 mg/mL) in 1 mL of PBS), mixed thoroughly, and then incubated for 5 min. In the end, cells were washed with PBS bovine serum albumin three times, and images were taken immediately under a fluorescent microscope (XDFL series, Sunny Instruments, China) [24].

2.5. Colony Formation Assay

In order to determine the antineoplastic effects on in vitro cell proliferation, the clonogenic assay was performed as described previously with minor modifications [25]. In brief, the cells were cultured for 24 h in T-25 tissue culture flasks and exposed to AHEE (IC₅₀) for 24 h. Afterward, trypsinization was performed on the cells; the cells were counted and seeded into a 6-well plate (200 cells/2 mL medium per well) and cultured for 8 days. Methanol was used to fix the colonies. Crystal violet (0.4 g/L) was used to stain the colonies, which were photographed, analyzed, and counted using ImageJ (v1.48) software. The formula for calculating the surviving cell fraction was

2.6. Annexin-V Apoptosis Assay

A 6-well plate was seeded with HCT-116 cells at a density of 3 × 10⁵ cells/2 mL and incubated in a CO₂ incubator at 37°C for 24 h. After removal of the spent medium, 1 mL of PBS was added. The cells were treated with AHEE (IC₅₀) in 2 mL of the culture medium and incubated for 12–16 h. An untreated well served as a negative control. At the end of incubation, the medium was removed from all the wells and transferred into 5 mL centrifuge tubes, which were then washed with 500 μL PBS. PBS was removed from the sample, and 200 μL of trypsin-EDTA solution was added and incubated for 3–4 min at 37°C. Afterward, the culture medium was transferred into the respective wells again and cells were harvested into the centrifuge tubes. The tubes were then centrifuged for 5 min at 300 × at 25°C. The supernatant was then removed and washed twice with PBS. The PBS was completely removed, and cells were resuspended in 1X binding buffer at a concentration of 1 × 10⁶ cells/ml. Following this, 100 μL of the solution (1 × 10⁵ cells) was transferred to a 5 mL culture tube and 5 μL of AbFlour 488 Annexin V was added. The cells were gently vortexed and incubated for 15 min at 25°C in the dark. At the end, 2 μL of PI and 400 μL of 1X binding buffer were added to each tube and vortexed gently. Analyses of the samples were carried out by flow cytometry immediately after the addition of PI [26].

2.7. Gene Expression Analysis

Tri-Pure Isolation Reagent (Sigma-Aldrich®, India, 11667157001) was used to isolate the cellular RNA according to the manufacturer’s instructions, and it was quantified with a nanodrop UV spectrophotometric analyzer (P 300, IMPLEN, USA). The RT-first strand synthesis kit (Qiagen, CA, USA, 330401) was used to reverse transcribe 1 μg of isolated RNA. SYBR green qRT-PCR (Applied Biosystems® 7500 Fast Real-Time PCR machine, CA, USA) was used to measure the gene expression levels relative to control. The 2^−ΔΔCt method was used for the analysis, with values expressed as fold changes over the control value. Each primer pair (Table 1) was used separately. The following conditions were used to determine the relative gene expression: reverse transcription was performed at 45°C for 45 minutes as a starting point, initial denaturation at 95°C with 10 min hold, followed by 40 cycles of 95°C for 15 sec, and 60°C for 60 sec [28].

2.8. GC-MS Analysis of A. hohenackerianum Crude Extract

Shimadzu Nexis GC-2030 equipped with a QP2020 NX mass spectrometer was used for the GC-MS analysis of AHEE. The helium was used as a carrier gas, which flowed at a rate of 1 mL/min. The GC-MS spectral detection method was based on electron ionization energy ionized at 70 eV, a scanning time of 0.2 s, and fragment masses in the range of 40 to 600 m/z. A volume of 1 μl and a temperature of 250°C were used for injection. Initially, a temperature of 50°C was set for 3 min in the column oven, then increased by 10°C per min to 280°C, and finally was set to 300°C for 10 min. A comparison of the phytochemicals present in the test samples with a library of authentic compounds maintained by the National Institute of Standards and Technology (NIST) revealed the presence of these compounds based on their mass spectral patterns, retention time (min), peak, area, and height [29].

2.9. Statistical Analysis

All experiments were carried out in triplicate. Results are presented as the mean ± SD of the number of experiments performed. The significance of the results was determined among the treatments using one-way ANOVA followed by Tukey’s post hoc test and Student’s t-test at . The analyses were carried out using GraphPad Prism 5.0 software.

3. Results

3.1. Cytotoxic Activity of A. hohenackerianum Crude Extract

To determine the cytotoxic activity, various concentrations of AHEE (1.56–200 μg/mL) were applied to A549, MCF-7, and HCT-116 cancer cells and then the IC₅₀ values were determined. A dose-response inhibition curve was used to determine the values after 48 hours. Figure 2 illustrates the dose-response curve of exposure of cancer cell lines to the crude extract. All tested cell lines were sensitive to the crude extract, among which the most sensitive cells were HCT-116 colon cancer cells (IC₅₀ = 123.90 μg/mL), more sensitive than MCF-7 breast cancer cells (IC₅₀ = 149.92 μg/mL) and lung cancer cells (IC₅₀ = 179.74 μg/mL). Therefore, the remaining assays were conducted on the HCT-116 cells. Cisplatin also showed dose-dependent inhibition of HCT-116 colon cancer cells (IC₅₀ = 25.95 μg/mL), MCF-7 breast cancer cells (IC₅₀ = 36.33 μg/mL), and lung cancer cells (IC₅₀ = 43.54 μg/mL).

(a)

(b)

(c)

(d)

3.2. S Phase Cell Accumulation

A flow cytometry assay was conducted to determine how AHEE affected the cell cycle of HCT-116 cells. An increase was observed in the percentage of cells that are in the S phase (40.30 ± 1.35) of the cell cycle in the cells treated with IC₅₀ of AHEE with a decline in the percentage of cells in G0/G1 (33.50 ± 1.19) and G2/M (19.80 ± 1.50) phases in comparison with the untreated control cells. This suggests that the treated cells are arrested in the S phase of the cell cycle (Figure 3).

(a)

(b)

3.3. Morphological Changes in HCT-116 Cells

To explore the morphological alterations caused by AHEE, HCT-116 cells were monitored using AO/EB staining. As compared with the control cells, the features of apoptotic cell death, including nuclear fragmentation, in the AHEE-treated cells were noticed (Figure 4). These results elucidated that the inhibition of AHEE on HCT-116 cell growth is linked with its induction of apoptosis.

(a)

(b)

3.4. Antiproliferative Potential of AHEE

The AHEE was examined for its effect on colony-forming ability in HCT-116 cells. Using AHEE, clonogenic assays were conducted to test the differences between untreated and treated cells in terms of reproductive viability. The colonies formed after 8 days were compared between cancer cells seeded with and without AHEE. A significant reduction in the number of colonies was observed in AHEE (Figure 5).

(a)

(b)

3.5. Quantification of Apoptotic Cell Death of AHEE-Treated Cells

The apoptosis induction by AHEE on HCT-116 cells was further confirmed using the Annexin-V and propidium iodide staining methods. The results of this experiment are shown in Figure 6. After treatment with IC₅₀, there was a significant increase from 0.51 ± 0.30% to 9.52 ± 0.92% and 2.80 ± 0.38% to 22.3 ± 1.23% of early and late apoptotic/necrotic cells, respectively.

(a)

(b)

3.6. Expression of Genes Related to Apoptosis

Real-time PCR was used to detect the expression level of the apoptotic genes p53, Bcl-2, and caspase-3 in HCT-116 cells treated with AHEE. Compared to untreated cells, expression levels of caspase-3 and p53 were significantly increased, whereas the expression levels of Bcl-2 were significantly decreased in AHEE-treated cells (Figure 7).

3.7. Identification of A. hohenackerianum Compounds by GC-MS

The AHEE was analyzed by GC-MS, and different classes of compounds were identified (Table 2). Among the main constituents are butanoic acid, 2,4,6-trimethyloctane, trans-linalool oxide, hexadecane, 1,10-decanediol, loliolide, n-hexadecanoic acid, n-nonadecanol-1, heneicosanoic acid-methyl ester, 10-nonadecanone, phytol, octacosanol, propanoic acid, 2-(benzoylamino)-3-phenyl-m, methyl (Z)-5,11,14,17-eicosatetraenoate, 4,8,12,16-tetramethylheptadecan-4-olide, gamma-sitosterol, hexadecanoic acid-2-hydroxy-1-(hydroxymethyl), octadecanoic acid, 2,3-dihydroxypropyl ester, and androsta-1,4-diene-3,17-dione (Figure 8).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)

(m)

(n)

(o)

(p)

(q)

(r)

(s)

Figure 8

Chemical structures of the identified compounds in AHEE via GC-MS analysis. (a) Butanoic acid, (b) 2,4,6-trimethyloctane, (c) trans-linalool oxide, (d) hexadecane, (e) 1,10-decanediol, (f) loliolide, (g) n-hexadecanoic acid, (h) n-nonadecanol-1, (i) heneicosanoic acid-methyl ester, (j) 10-nonadecanone, (k) phytol, (l) octacosanol, (m) propanoic acid, 2-(benzoylamino)-3-phenyl-m, (n) methyl (Z)-5,11,14,17-eicosatetraenoate, (o) 4,8,12,16-tetramethylheptadecan-4-olide, (p) gamma-sitosterol, (q) hexadecanoic acid-2-hydroxy-1-(hydroxymethyl), (r) octadecanoic acid, 2,3-dihydroxypropyl ester, and (s) androsta-1,4-diene-3,17-dione.

4. Discussion

Medicinal plants have been the known source of medicines for the treatment of various ailments since ancient times. People around the globe have implemented the usage of botanicals for millennia. Although angiosperms and other higher plants have been extensively studied for their medicinal and economic value, ferns and fern-allies have been completely overlooked. There is a strong emphasis on its use in Ayurvedic (Sushruta, Charka, and Samhita), Unani, Homeopathic, and other systems of medicine. People use them in the treatment of different kinds of illnesses like burns, colds, ascarid diseases, bleeding due to trauma, and diarrhea [30]. Preliminary screening on different sorts of bioactivities of traditional medicinal ferns has been reported [31–36]. However, no in-depth studies on any biological activities of these plants exist.

A. hohenackerianum contains a wide array of phytochemical constituents, making it one of the most valuable medicinal plants [37]. In this study, A. hohenackerianum was extracted using ethanol to obtain the largest amount of bioactive phytochemicals. Based on the results of this study, we found that the ethanolic extract of A. hohenackerianum conferred high cytotoxic activity on a variety of cancer cells, with good efficacy against human colon cancer cells HCT-116. In addition, we showed that the ethanolic extract of A. hohenackerianum arrests the cell cycle at the S phase and specifically induces apoptosis. This fact has been supported by numerous experiments, including labeling with Annexin V-/PI and activation of apoptosis signaling molecules. This study’s findings are consistent with a prior study that found other species of Athyrium extracts have antiproliferative agents against several cancer cells. It has been reported that A. multidentatum shows cytotoxic activity against hepatocellular carcinoma (HepG2 cells) with IC₅₀ values of 220 μg/mL and 114 μg/mL after 24 h and 48 h, respectively [38]. It was also reported that A. multidentatum crude extract causes cytotoxicity in HL-7702 liver cells with IC₅₀ values of 332 μg/mL and 304 μg/mL after 24 h and 48 h, respectively [39]. The butenolide derivative Striatisporolide A of A. multidentatum exhibits potent cytotoxic activity against human lung cancer cells (A549) with an IC₅₀ of 7.75 μg/mL [39].

To investigate the mechanisms involved in the growth inhibition of HCT-116 cells treated with A. hohenackerianum, the cell cycle distribution was analyzed. In the present study, it was found that cells treated with A. hohenackerianum accumulated at the S phase of cells, and therefore, this suggests that HCT-116 cells undergo apoptosis since accumulation of cells at this phase is considered a biomarker for DNA damage as well as an indicator of cell death by apoptosis [40]. As part of the confirmation of apoptosis induction, the Annexin-V/PI apoptosis detection assay was used, which is widely used to distinguish both early and late stages of apoptosis [41]. The apoptotic cell death mode of A. hohenackerianum was confirmed by a shift toward early and late apoptotic cell populations, suggesting the extract exerted an apoptotic effect. The dual staining of Annexin-V/PI and the cells accumulated in the S phase, as well as the morphological changes that occurred during the cell death evident with AO/EB after treatment with A. hohenackerianum crude extract, strongly indicate that the cells are undergoing apoptosis. It is well known that intact plasma membrane integrity can be used as a major indicator of apoptotic cells morphologically [42, 43]. In contrast to apoptosis, necrosis is characterized by a loss of integrity in the cell membrane [42]. The dual AO/EB fluorescent staining method is convenient for detecting changes in cell membranes caused by apoptosis. The AO binds to DNA in intact cells and emits green fluorescence. In damaged cells, EB penetrates the membrane and binds to the DNA and fluorescence of orange-red is emitted [44]. Therefore, AO allows the staining of apoptotic cells as well as live cells, and EB permits the staining of both necrotic and late apoptotic cells.

Furthermore, we also performed a more prolonged clonogenic survival test and found that A. hohenackerianum inhibited the survival of HCT-116 cells for a longer period of time. As a result, it should be noted that the crude extract of A. hohenackerianum has the potential to be used as a treatment or management for colon cancer, since targeting a cell population that is clonogenic/tumor-initiating/stemlike is believed to be essential for success with cancer therapy.

The apoptotic process is regulated by genes such as p53, caspase-3, and Bcl-2 [45]. A qRT-PCR technique was used to analyze the expression of these apoptotic genes to support the results from the flow cytometry. Compared to the control, treatment with the extracts significantly lowered the antiapoptotic Bcl-2 gene and significantly increased the apoptotic Bax and caspase-3 genes, indicating that A. hohenackerianum acts through caspase-dependent apoptotic pathways. It has been reported that a similar event occurred in many studies in which natural product extracts increased the expression of these genes in different human cancer cells, thus causing them to undergo apoptosis [46–49]. Overall, our study confirms that A. hohenackerianum induces apoptosis in HCT-116 cancer cells.

The medicinal properties of plant extracts are largely due to the secondary products that act in synergism rather than as a single compound [50–52]. GC/MS is a useful and dependable method for identifying complex plant extracts in an efficient and timely manner [53]. This study identified different classes of phytochemical constituents of A. hohenackerianum as having an inhibitory effect on colorectal cancer cells’ growth [54], suggesting that these compounds may play a role in the observed activity against HCT-116 colon cancer cells. The natural compound butyric acid is found in food. The anticancer activity of butyric acid has been reported against acute myeloid leukemia, Lewis lung carcinoma cells, and colorectal carcinoma cells [55]. Linalool showed the strongest activity against a broad range of cancers, such as carcinoma of the cervix, stomach, skin, lung, and bone with IC₅₀ ranging from 82.3 to 113.6 μg/mL [56]. Phytol is a substance found in chlorophyll and has been shown to be cytoprotective against oxidative stress. The anticancer and immune-enhancing properties of phytol are well-documented. By regulating macrophage function, phytol not only enhances natural killer cells that remove cancer cells but also strengthens immunity. There is evidence that phytol has an anticancer effect against breast, prostate, cervical, colorectal, lung, and skin cancers, with IC₅₀ values ranging from 15.51 to 69.67 μM [57]. Gamma-sitosterol is a compound that belongs to the stigmastanes and derivatives family of organic compounds. It has also anticancer effects against several types of cancer including, breast, lung, hepatocellular, and colorectal cancer [58]. Therefore, it can be concluded that the anticancer effects seen in the extract could be due to the presence of these compounds.

5. Conclusion

The ethanolic extract of A. hohenackerianum inhibited the proliferation of various cancer cells. In particular, we demonstrated that the A. hohenackerianum extract inhibits the growth of HCT-116 colon cancer cells by apoptosis by inducing cell arrest in the S phase and causing dose-dependent rises in early and late apoptotic cell populations. Moreover, upregulation of apoptosis gene markers in HCT-116 cells confirmed the initiation of apoptosis by A. hohenackerianum. Based on preliminary findings, A. hohenackerianum has the potential to be a new natural source of anticolon cancer compound(s) that can trigger apoptotic cell death. However, despite the numerous advantages, toxicity concerns are always present with the variety of plants and can be unsafe for the sensitive populations. Therefore, in vivo toxicological assessment is a mandatory requirement and must be done prior to the drug development, which is a limitation in this study. Furthermore, certain assays such as migration assay, angiogenesis assay, and protein expression by Western blotting can also be performed to confirm the efficacy of A. hohenackerianum and identify the possible cellular and molecular mechanisms involved in the anticancer activity.

Data Availability

All data generated or analyzed during this study are included in this article.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Authors’ Contributions

Abdelbaset Mohamed Elasbali was responsible for conceptualization, original draft preparation, data curation, investigation, and methodology. Waleed Abu Al-Soud involved in data analysis, validation, and visualization. Ziad H. Al-Oanzi participated in formal analysis, investigation, and validation. Husam Qanash and Alharbi Bandar performed formal analysis, investigation, and validation. Naif K Binsaleh took part in data curation, validation, review, and editing. Mousa Alreshidi was responsible for data curation, validation, review, and editing. Mitesh Patel performed methodology, review, and editing. Mohd. Adnan contributed to conceptualization, data analysis, validation, project administration, review, and editing.

Acknowledgments

The authors extend their appreciation to the Deputyship for Research and Innovation, Ministry of Education in Saudi Arabia for funding this work through grant no. 1172659343. The authors would like to extend their sincere appreciation to the Central Laboratory at Jouf University for supporting this study.

References

F. Bray, J. Ferlay, I. Soerjomataram, R. L. Siegel, L. A. Torre, and A. Jemal, “Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries,” CA: A Cancer Journal for Clinicians, vol. 68, no. 6, pp. 394–424, 2018.
View at: Publisher Site | Google Scholar
H. Sung, J. Ferlay, R. L. Siegel et al., “Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries,” CA: A Cancer Journal for Clinicians, vol. 71, no. 3, pp. 209–249, 2021.
View at: Google Scholar
Q. Y. Zhang, F. X. Wang, K. K. Jia, and L. D. Kong, “Natural Product Interventions for Chemotherapy and Radiotherapy-Induced Side Effects,” Frontiers in pharmacology., vol. 9, p. 1253, 2018.
View at: Publisher Site | Google Scholar
J. Iqbal, B. A. Abbasi, T. Mahmood et al., “Plant-derived anticancer agents: a green anticancer approach,” Asian Pacific Journal of Tropical Biomedicine, vol. 7, no. 12, pp. 1129–1150, 2017.
View at: Publisher Site | Google Scholar
A. G. Desai, G. N. Qazi, R. K. Ganju et al., “Medicinal plants and cancer chemoprevention,” Current Drug Metabolism, vol. 9, no. 7, pp. 581–591, 2008.
View at: Publisher Site | Google Scholar
D. Al-Eisawi and S. Al-Ruzayza, “The flora of holy Mecca district, Saudi Arabia,” International Journal of Biodiversity and Conservation, vol. 7, pp. 173–189, 2015.
View at: Google Scholar
R. Di Novella, N. Di Novella, L. De Martino, E. Mancini, and V. De Feo, “Traditional plant use in the national park of cilento and vallo di Diano, Campania, southern, Italy,” Journal of Ethnopharmacology, vol. 145, no. 1, pp. 328–342, 2013.
View at: Publisher Site | Google Scholar
M. Eskandari, B. Riazi, S. Shirzadian, and A. Mazooji, “A study of threatened species of ferns in Gilan province (N Iran) providing a comparison of protective classification of conservation based on IUCN’s factors,” Rostaniha, vol. 13, pp. 1–9, 2012.
View at: Google Scholar
V. A. Mozaffarian, Identification of Medicinal and Aromatic Plants of Iran, FarhangeMoaser Press, Tehran, Iran, 2012.
M. B. Bahadori, F. M. Kordi, A. A. Ahmadi, S. Bahadori, and H. Valizadeh, “Antibacterial evaluation and preliminary phytochemical screening of selected ferns from Iran,” Research Journal of Pharmacognosy, vol. 2, pp. 53–59, 2015.
View at: Google Scholar
P. Parihar and L. Parihar, “Some pteridophytes of medicinal importance from Rajasthan,” Natural Product Radiance, vol. 5, pp. 297–301, 2006.
View at: Google Scholar
M. S. Vyas and B. D. Sharma, Today and Tomorrow, Sprinters and Publishers, Daryaganj, India, 1988.
S. K. Sarker and A. B. M. E. Hossain, “Pteridophytes of greater mymensingh district of Bangladesh used as vegetables and medicines,” Bangladesh Journal of Plant Taxonomy, vol. 16, pp. 47–56, 2009.
View at: Google Scholar
B. P. Singh and R. Upadhyay, “Medicinal pteridophytes of Madhya Pradesh,” Journal of medicinal plants studies, vol. 2, pp. 65–68, 2014.
View at: Google Scholar
G. Sathiyaraj, T. Muthukumar, and K. C. Ravindran, “Ethno medicinal importance of fern and fern- allies traditionally used by tribal people of Palani Hills (Kodaikanal), Western Ghats, South India,” The Journal of Medicinal Herbs and Ethnomedicine, vol. 1, pp. 4–9, 2015.
View at: Publisher Site | Google Scholar
D. Corrigan, “Medicinal Plants in Folk Tradition−an Ethnobotany of Britain and Ireland By David E. Allen and Gabrielle Hatfield (Natural History Museum, London, and the Royal Botanic Gardens, Kew). Timber Press, Portland, OR. 2004. 431 pp. 9^1/4 × 6^1/4 in. $29.95. ISBN 0-88192-638-8,” Journal of Natural Products, vol. 67, no. 12, p. 2154, 2004.
View at: Publisher Site | Google Scholar
J. M. Powell, “Ethnobotany,” New Guinea Vegetation, Australian National University Press, Canberra, 1976.
View at: Google Scholar
Y. Liu, W. Wujisguleng, and C. Long, “Food uses of ferns in China: a review,” Acta Societatis Botanicorum Poloniae, vol. 81, no. 4, pp. 263–270, 2012.
View at: Publisher Site | Google Scholar
G. Qi, L. Yang, C. Xiao, J. Shi, Y. Mi, and X. Liu, “Nutrient values and bioactivities of the extracts from three fern species in China: a comparative assessment,” Food & Function, vol. 6, no. 9, pp. 2918–2929, 2015.
View at: Publisher Site | Google Scholar
J. W. Sheng, D. M. Liu, Z. J. Li, L. Qi, and W. F. Zhang, “Bioactivity-guided fractionation for antioxidant property of Athyrium multidentatum (Doll) Ching. rhizome,” Journal of Medicinal Plants Research, vol. 5, pp. 7000–7005, 2011.
View at: Google Scholar
S. D. Shaikh, V. P. Masal, and A. S. Shaikh, “Ethnomedicinal uses of some pteridophytes from Konkan region of Maharashtra, India,” International Journal of Pharmaceutical and Chemical Sciences, vol. 3, pp. 62–65, 2014.
View at: Google Scholar
M. Adnan, A. J. Siddiqui, W. S. Hamadou et al., “Deciphering the Molecular Mechanism Responsible for Efficiently Inhibiting Metastasis of Human Non-Small Cell Lung and Colorectal Cancer Cells Targeting the Matrix Metalloproteinases by Selaginella repanda,” Plants, vol. 10, p. 979, 2021.
View at: Google Scholar
P. Pozarowski and Z. Darzynkiewicz, “Analysis of cell cycle by flow cytometry,” Methods in Molecular Biology, vol. 281, pp. 301–311, 2004.
View at: Publisher Site | Google Scholar
R. Shakeri, J. Khorshidi, T. Radjabian, A. Lashkari, and M. Safavi, “Cytotoxic and Antioxidant Activities of Crocus pallasii subsp. haussknechtii Corms Extracts Compared with Crocus sativus,” Research Journal Pharmacognosy, vol. 6, pp. 51–59, 2019.
View at: Google Scholar
N. A. P. Franken, H. M. Rodermond, J. Stap, J. Haveman, and C. van Bree, “Clonogenic assay of cells in vitro,” Nature Protocols, vol. 1, no. 5, pp. 2315–2319, 2006.
View at: Publisher Site | Google Scholar
I. Vermes, C. Haanen, and H. Steffens-Nakken, “A novel assay for apoptosis Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V,” Journal of Immunological Methods, vol. 184, no. 1, pp. 39–51, 1995.
View at: Publisher Site | Google Scholar
M. Behbahani, “Evaluation of in vitro anticancer activity of Ocimum basilicum, Alhagi maurorum, Calendula officinalis and their parasite Cuscuta campestris,” PLoS One, vol. 9, no. 12, Article ID e116049, 2014.
View at: Publisher Site | Google Scholar
N. Abutaha, F. A. Nasr, M. Al-zharani et al., “Effects of hexane root extract of ferula hermonis boiss. on human breast and colon cancer cells: an in vitro and in vivo study,” BioMed Research International, vol. 2019, Article ID 3079895, 2019.
View at: Publisher Site | Google Scholar
M. Adnan, A. J. Siddiqui, W. S. Hamadou et al., “Functional and structural characterization of pediococcus pentosaceus-derived biosurfactant and its biomedical potential against bacterial adhesion, quorum sensing, and biofilm formation,” Antibiotics, vol. 10, no. 11, p. 1371, 2021.
View at: Publisher Site | Google Scholar
A. Benjamin and V. S. Manickam, “Medicinal pteridophytes from the Western Ghats,” Natural Product Reports, vol. 6, pp. 611–618, 2007.
View at: Google Scholar
M. Singh, N. Singh, P. B. Khare, and A. K. S. Rawat, “Antimicrobial activity of some important Adiantum species used traditionally in indigenous systems of medicine,” Journal of Ethnopharmacology, vol. 115, no. 2, pp. 327–329, 2008.
View at: Publisher Site | Google Scholar
S. L. Shin and C. H. Lee, “Antioxidant effects of the methanol extracts obtained from aerial part and rhizomes of ferns native to Korea,” Korean Journal of Polar Research, vol. 23, pp. 38–46, 2010.
View at: Publisher Site | Google Scholar
A. R. McCutcheon, T. E. Roberts, E. Gibbons et al., “Antiviral screening of British Columbian medicinal plants,” Journal of Ethnopharmacology, vol. 49, no. 2, pp. 101–110, 1995.
View at: Publisher Site | Google Scholar
C. Punzón, A. Alcaide, and M. Fresno, “In vitro anti-inflammatory activity of Phlebodium decumanum. Modulation of tumor necrosis factor and soluble TNF receptors,” International Immunopharmacology, vol. 3, no. 9, pp. 1293–1299, 2003.
View at: Publisher Site | Google Scholar
Y. Mizushina, I. Watanabe, H. Togashi et al., “An Ergosterol Peroxide, a natural product that selectively enhances the inhibitory effect of linoleic acid on DNA polymerase .BETA,” Biological and Pharmaceutical Bulletin, vol. 21, no. 5, pp. 444–448, 1998.
View at: Publisher Site | Google Scholar
M. Konoshima, H. Chi, and K. Hata, “Coumarins from the root of Angelica gigas NAKAI,” Chemical and Pharmaceutical Bulletin, vol. 16, no. 6, pp. 1139-1140, 1968.
View at: Publisher Site | Google Scholar
J. Sheng and Y. Sun, “Antioxidant properties of different molecular weight polysaccharides from Athyrium multidentatum (Doll.) Ching,” Carbohydrate Polymers, vol. 108, pp. 41–45, 2014.
View at: Publisher Site | Google Scholar
G. Qi, Z. Liu, R. Fan et al., “Athyrium multidentatum (Doll.) Ching extract induce apoptosis via mitochondrial dysfunction and oxidative stress in HepG2 cells,” Scientific Reports, vol. 7, p. 2275, 2017.
View at: Publisher Site | Google Scholar
D. M. Liu, J. W. Sheng, S. H. Wang, W. F. Zhang, W. Zhang, and D. J. Zhang, “Cytoproliferative and cytoprotective effects of Striatisporolide A isolated from Rhizomes of Athyrium multidentatum (Doell.) ching on human umbilical vein endothelial cells,” Molecules, vol. 21, no. 10, p. 1280, 2016.
View at: Publisher Site | Google Scholar
C. Riccardi and I. Nicoletti, “Analysis of apoptosis by propidium iodide staining and flow cytometry,” Nature Protocols, vol. 1, no. 3, pp. 1458–1461, 2006.
View at: Publisher Site | Google Scholar
A. P. Demchenko, “Beyond annexin V: fluorescence response of cellular membranes to apoptosis,” Cytotechnology, vol. 65, no. 2, pp. 157–172, 2013.
View at: Publisher Site | Google Scholar
I. Vermes, C. Haanen, and C. Reutelingsperger, “Flow cytometry of apoptotic cell death,” Journal of Immunological Methods, vol. 243, no. 1-2, pp. 167–190, 2000.
View at: Publisher Site | Google Scholar
Y. Zhang, X. Chen, C. Gueydan, and J. Han, “Plasma membrane changes during programmed cell deaths,” Cell Research, vol. 28, no. 1, pp. 9–21, 2018.
View at: Publisher Site | Google Scholar
K. Liu, P. C. Liu, R. Liu, and X. Wu, “Dual AO/EB staining to detect apoptosis in osteosarcoma cells compared with flow cytometry,” Medical science monitor basic research, vol. 21, pp. 15–20, 2015.
View at: Publisher Site | Google Scholar
Y. Kiraz, A. Adan, M. Kartal Yandim, and Y. Baran, “Major apoptotic mechanisms and genes involved in apoptosis,” Tumor Biology, vol. 37, no. 7, pp. 8471–8486, 2016.
View at: Publisher Site | Google Scholar
E. Chamani, Z. Rezaei, K. Dastjerdi, S. Javanshir, K. Khorsandi, and G. A. Mohammadi, “Evaluation of some genes and proteins involved in apoptosis on human chronic myeloid leukemia cells (K562 cells) by datura innoxia leaves aqueous extract,” Journal of Biomolecular Structure and Dynamics, vol. 38, no. 16, pp. 4838–4849, 2020.
View at: Publisher Site | Google Scholar
A. M. G. Zedan, M. I. Sakran, O. Bahattab et al., “Oriental Hornet (Vespa orientalis) larval extracts induce antiproliferative, antioxidant, anti-inflammatory, and anti-migratory effects on MCF7 Cells,” Molecules, vol. 26, no. 11, p. 3303, 2021.
View at: Publisher Site | Google Scholar
G. H. Mansour, M. A. El-Magd, D. H. Mahfouz et al., “Bee venom and its active component Melittin synergistically potentiate the anticancer effect of Sorafenib against HepG2 cells,” Bioorganic Chemistry, vol. 116, Article ID 105329, 2021.
View at: Publisher Site | Google Scholar
N. M. Selim, A. A. Elgazar, N. M. Abdel-Hamid et al., “Chrysophanol, physcion, hesperidin and curcumin modulate the gene expression of pro-inflammatory mediators induced by LPS in HepG2: In silico and molecular studies,” Antioxidants, vol. 8, no. 9, p. 371, 2019.
View at: Publisher Site | Google Scholar
P. Jigna, N. Rathish, and C. Sumitra, “Preliminary screening of some folklore medicinal plants from western India for potential antimicrobial activity,” Indian Journal of Pharmacology, vol. 37, pp. 408-409, 2005.
View at: Google Scholar
A. Badawy, H. Hassanean, A. K. Ibrahim, E. S. Habib, M. A. El-Magd, and S. A. Ahmed, “Isolates from Thymelaea Hirsuta inhibit progression of Hepatocellular Carcinoma in vitro and in vivo,” Natural Product Research, vol. 35, no. 11, pp. 1799–1807, 2021.
View at: Publisher Site | Google Scholar
A. A. A. Khamis, E. M. M. Ali, M. A. A. El-Moneim, M. M. Abd-Alhaseeb, M. A. El-Magd, and E. I. Salim, “Hesperidin, piperine and bee venom synergistically potentiate the anticancer effect of tamoxifen against breast cancer cells,” Biomedicine & pharmacotherapy, vol. 105, pp. 1335–1343, 2018.
View at: Publisher Site | Google Scholar
A. Iordache, M. Culea, C. Gherman, and O. Cozar, “Characterization of some plant extracts by GC–MS,” Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atom, vol. 267, no. 2, pp. 338–342, 2009.
View at: Publisher Site | Google Scholar
R. Sankaranarayanan, C. K. Valiveti, R. Dachineni, D. R. Kumar, T. Lick, and G. J. Bhat, “Aspirin metabolites 2,3^-DHBA and 2,5^-DHBA inhibit cancer cell growth: Implications in colorectal cancer prevention,” Molecular Medicine Reports, vol. 21, pp. 20–34, 2020.
View at: Publisher Site | Google Scholar
L. Pattayil and H. T. Balakrishnan-Saraswathi, “In vitro evaluation of apoptotic induction of butyric acid derivatives in colorectal carcinoma cells,” Anticancer Research, vol. 39, no. 7, pp. 3795–3801, 2019.
View at: Publisher Site | Google Scholar
G. P. P. Kamatou and A. M. Viljoen, “Linalool–A review of a biologically active compound of commercial importance,” Natural Product Communications, vol. 3, no. 7, 2008.
View at: Publisher Site | Google Scholar
B. Pejin, V. Kojic, and G. Bogdanovic, “An insight into the cytotoxic activity of phytol at in vitro conditions,” Natural Product Research, vol. 28, no. 22, pp. 2053–2056, 2014.
View at: Publisher Site | Google Scholar
S. Sundarraj, R. Thangam, V. Sreevani et al., “γ-Sitosterol from Acacia nilotica L. induces G2/M cell cycle arrest and apoptosis through c-Myc suppression in MCF-7 and A549 cells,” Journal of Ethnopharmacology, vol. 141, no. 3, pp. 803–809, 2012.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2022 Abdelbaset Mohamed Elasbali et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

1215

Downloads

711

Citations